
Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares
ZEPPDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| April 15, 2022 | $0.10 | 2022-03-25 | 2022-03-28 |
Dividends Summary
- Consistent Payer: Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares has rewarded shareholders with 1 dividend payments over the past 0 years.
- Total Returned Value: Investors who held ZEPP shares during this period received a total of $0.10 per share in dividend income.
- Latest Payout: The most recent dividend of $0.10/share was paid 1555 days ago, on April 15, 2022.
Company News
Zepp Health, a health wearables company, experienced a dramatic stock surge of nearly 1,100% in six months, driven by strong Q2 and Q3 revenue growth and robust sales of Amazfit wearables, despite historical challenges.
Zepp Health has experienced significant growth in 2025, transitioning from Xiaomi-branded wearables to its own Amazfit brand, resulting in a 46% revenue increase and a 1,900% stock price surge.
The personalized retail nutrition and wellness market is expected to expand from $4.54 billion in 2025 to $16.25 billion by 2034, driven by increasing health awareness, technological advancements, and a shift towards holistic wellness approaches.
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Peraso posted a quarterly loss of $8.52 per share, versus analysts’ estimates for a loss of $3.76 per share. The company’s quarterly sales came in at $1.83 million versus expectations of $1.7...
Gainers SenesTech, Inc. (NASDAQ: SNES) shares rose 65.8% to $0.3847 in pre-market trading after declining over 3% on Tuesday. Zovio Inc (NASDAQ: ZVO) rose 38.2% to $0.2765 in pre-market trading after jumping around 39% on Tuesday. Kintara Therapeutics, Inc. (NASDAQ: KTRA) rose 37% to $0.1371 in pre-market trading after gaining over 6% on Tuesda...

